文献速递胃肠外科围术期管理与 ERAS

袖状胃切除术后胃食管反流病的机器人辅助治疗

Robotic-assisted approaches to GERD following sleeve gastrectomy.
PubMed 文献 · Surg Endosc · 2020-06-22

本研究回顾性分析51例患者,比较机器人辅助磁性括约肌增强术(MSA)治疗无减重手术史的GERD(18例)、袖状胃切除术后GERD行MSA(13例)或转换为Roux-en-Y胃旁路术(RYGB,20例)的围手术期结果。三组在年龄、性别、ASA评分、内镜表现及DeMeester评分上无显著差异,RYGB组BMI显著更高。MSA与RYGB组及MSA-S与RYGB组手术时间有显著差异,但MSA与MSA-S组无差异;术中及术后并发症无显著差异,各组停用PPI成功率均超过80%。

要点

  • 机器人辅助MSA或RYGB治疗袖状胃切除术后GERD可行,并发症低。
  • 各组停用PPI成功率均超过80%,症状缓解满意。
  • RYGB手术时间显著长于MSA及MSA-S,但并发症无差异。

核心结论

  • 机器人平台用于袖状胃切除术后GERD的MSA或RYGB治疗是可行选择,并发症低且成功率高。

研究设计与样本

  • 回顾性队列研究,纳入2015至2019年连续患者51例,分为MSA组18例、MSA-S组13例、RYGB组20例。

主要发现

  • 三组年龄、性别、ASA评分、术前内镜表现及DeMeester评分无显著差异(P>0.05)。
  • RYGB组BMI显著高于MSA组和MSA-S组(P<0.0001)。
  • MSA与RYGB组手术时间有显著差异(P<0.0001),MSA-S与RYGB组也有显著差异(P=0.009),MSA与MSA-S组无差异(P=0.51)。
  • 术中及术后并发症无显著差异(P=1.0和P=0.60),30天并发症率分别为MSA 5.6%、MSA-S 15.4%、RYGB 15%。
  • 各组停用PPI成功率均超过80%,组间无差异。

临床怎么用

  • 袖状胃切除术后顽固性GERD可考虑机器人辅助MSA或RYGB,需个体化选择。

局限性

  • 样本量小(51例),回顾性设计,需进一步数据支持。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sleeve gastrectomy (SG) is the most common bariatric operation in the United States but increases the incidence of gastroesophageal reflux disease (GERD). The aim of our study was to describe our experience with robotic-assisted management of intractable GERD after SG. METHODS: A systematic review of a prospectively maintained database was performed of consecutive patients undergoing robotic-assisted magnetic sphincter augmentation placement after sleeve gastrectomy (MSA-S group) or conversion to Roux-en-Y gastric bypass (RYGB group) for GERD from 2015 to 2019 at our tertiary- care bariatric center. These were compared to a consecutive group of patients undergoing robotic-assisted magnetic sphincter augmentation placement (MSA group) for GERD without a history of bariatric surgery from 2016 to 2019. The primary outcome was perioperative morbidity. Secondary outcomes were operative time (OT), 90-day re-intervention rate, length of stay, symptom resolution and weight change. RESULTS: There were 51 patients included in this study; 18 patients in the MSA group, 13 patients in the MSA-S group, and 20 patients in the RYGB group. There was no significant difference in age, gender, ASA score, preoperative endoscopic findings, or DeMeester scores (P > 0.05). BMI was significantly higher in patients undergoing RYGB compared to MSA or MSA-S (P < 0.0001). There were significant differences in OT between the MSA and RYGB groups (P < 0.0001) and MSA-S and RYGB groups (P = 0.009), but not MSA group to MSA-S group (P = 0.51). There was no significant difference in intraoperative and postoperative morbidity (P = 1.0 and P = 0.60, respectively). 30-day morbidity: 5.6% (MSA), 15.4% (MSA-S) and 15% (RYGB). There was no difference on PPI discontinuation among groups, with more than 80% success rate in all. CONCLUSIONS: The use of the robotic platform in the different approaches available for treatment of GERD after SG appears to be a feasible option with low morbidity and high success rate. Further data is needed to support our findings.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Bellorin O, Dolan P, Vigiola-Cruz M, et al. Robotic-assisted approaches to GERD following sleeve gastrectomy. Surg Endosc. 2020. PMID: 32572629. doi:10.1007/s00464-020-07753-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。